Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
24-month extension study of sotrastaurin versus Neoral in de novo adult renal transplant recipients
2008-000531-18Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sotrastaurin in kidney transplant (2 arms), sponsored by Novartis. Primary endpoints: Composite efficacy endpoint and Renal function safety profile. Started Jul 2008; status: terminated.
02
Drugs
sotrastaurin
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2008-000531-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000531-18.